CVS Health Corp. reported quarterly results on Wednesday that beat analysts’ estimates on higher demand for COVID-19 tests and vaccinations due to the Omicron variant, while the drugstore operator also reaffirmed its annual earnings forecast.
The company administered over 8 million COVID-19 tests and more than 20 million COVID-19 vaccines across the United States during the quarter.
